New Antifungal Drugs, New Approaches and Vaccines

Inhibition of ceramide de novo synthesis by myriocin produces the double effect of reducing pathological inflammation and exerting antifungal activity against A. fumigatus airways infection

10 October 2016

Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm

30 October 2015

Drugs in Clinical Development for Fungal Infections (review includes CD101)

5 October 2017

Novamycin: ECCMID poster

5 October 2017

Novamycin: short talk from Dr Deborah O’Neill at Boulder Peptide Society

5 October 2017

Novamycin (NP339)

5 October 2017

Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi.

13 September 2017

CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program.

8 September 2017

Antitumor/Antifungal Celecoxib Derivative AR-12 is a Non-Nucleoside Inhibitor of the ANL-Family Adenylating Enzyme Acetyl CoA Synthetase.

23 February 2016

AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.

1 October 2016